session highlights: clinical indications for car-t therapy in multiple myeloma
Published 1 year ago • 59 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
0:48
selecting patients with multiple myeloma for car-t therapy
-
4:12
car-t therapy in multiple myeloma: recent updates, clinical trials and future outlooks
-
1:06
moving car-t therapy to earlier lines in multiple myeloma and clinical trials in this space
-
14:10
highlights in multiple myeloma: improving access to car-t therapy, novel targets & future outlooks
-
1:53
car-t therapy in multiple myeloma: research blind spots
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
3:03
session highlights: integrating cellular therapy in myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
0:50
car-t in multiple myeloma: cilta-cel & ide-cel
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
1:01
the potentially curative role of car-t therapy in myeloma
-
1:47
clinical outcomes of patients with r/r multiple myeloma listed for treatment with car-t therapy
-
1:38
how to optimize access to car-t cell therapies in multiple myeloma
-
2:01
car-t updates in myeloma
-
1:38
challenges of car-t therapy in the real-world setting
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
2:30
an update on the current status of car-t therapy in multiple myeloma
-
1:33
patient selection for car-t in all